Keywords: zerit/3tc, effective, azt/3tc, six-month, interim, results, aids
Zerit/3TC More Effective Than AZT/3TC
Article | 20 October 1997
Six-month interim results from the AIDS Clinical Trial Group Study 306have shown that patients who received Bristol-Myers Squibb's nucleoside analog ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
